ClinicalTrials.Veeva

Menu

Suprascapular and Axillary Versus Interscalene Blocks Regarding Phrenic Affection in Shoulder Surgeries

A

Ain Shams University

Status

Not yet enrolling

Conditions

Shoulder Surgery
Suprascapular Nerve
Interscalene Nerve Block

Treatments

Procedure: Suprascapular nerve block and Axillary nerve block
Procedure: Interscalene Nerve Block

Study type

Interventional

Funder types

Other

Identifiers

NCT06674551
FMASU MD128/2024

Details and patient eligibility

About

This study is aims to compare between combined suprascapular and axillary nerve blocks versus interscalene nerve block regarding phrenic nerve affection assessed by ultrasound guided diaphragmatic excursion in shoulder arthroscopy surgeries.

Full description

Interscalene approach of brachial plexus nerve block is recognized as the gold standard technique for postoperative pain control after shoulder arthroscopy surgeries . However, it is associated with major adverse effects and possibly critical complications including phrenic nerve affection. Combined suprascapular and axillary nerve blocks are considered to be a safe and effective alternative to interscalene nerve block for shoulder surgery. Futher studies had been done regarding postoperative analgesia after shoulder arthroscopy surgeries using intersalene nerve block versus suprascapular and axillary nerve blocks.

In this study, we will Compare between combined suprascapular and axillary nerve blocks vs interscalene nerve block regarding objective phrenic nerve affection known as a serious complication of interscalene nerve block.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged between 18 - 60 years old.
  • Both sexes.
  • ASA physical status classes I - II.
  • Body mass index: 18-35 kg/ m2.

Exclusion criteria

  • Infection at site of injection.
  • Psychiatric illness.
  • Central Nervous System Diseases like (epilepsy, stroke ...etc.) or neurological disease affecting patient's upper limb.
  • Dependence on opiates and psycho-dynamic medications.
  • Moderate to severe pulmonary disease.
  • Coagulopathy and bleeding disorders.
  • Allergies to drug used (Bupivacaine 0.5%).
  • Previous surgery at site of injection and history of radiotherapy.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Suprascapular nerve block and Axillary nerve block ( Group A)
Experimental group
Description:
Patients will receive Suprascapular nerve block (SSNB) and Axillary nerve block (AXNB) 30 minutes before the induction of general anaesthesia.
Treatment:
Procedure: Suprascapular nerve block and Axillary nerve block
Interscalene nerve block (Group B)
Experimental group
Description:
Patients will receive Interscalene nerve block (ISB) 30 minutes before the induction of general anaesthesia.
Treatment:
Procedure: Interscalene Nerve Block

Trial contacts and locations

0

Loading...

Central trial contact

Mohamed Khaled Mahmoud, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems